[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

China mRNA Vaccines & Therapeutics Market Research Report 2018

March 2018 | 107 pages | ID: CAACA9B6F6BQEN
QYResearch

US$ 3,400.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global mRNA Vaccines & Therapeutics market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the mRNA Vaccines & Therapeutics development status and future trend in China, focuses on top players in China, also splits mRNA Vaccines & Therapeutics by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
  • Argos Therapeutics
  • AstraZeneca
  • Bayer
  • BioNTech
  • Boehringer Ingelheim
  • CRISPR Therapeutics
  • CureVac
  • eTheRNA immunotherapies
  • Ethris
  • GlaxoSmithKline Vaccines
  • In-Cell-Art
  • Intellia Therapeutics
  • Janssen
  • Kernal Biologics
  • MaxCyte
  • Moderna Therapeutics
  • Novartis
  • PhaseRx
  • Precision NanoSystems
  • RaNa Therapeutics
Geographically, this report splits the China market into six regions,
  • South China
  • East China
  • Southwest China
  • Northeast China
  • North China
  • Central China
  • Northwest China
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
  • Standardization Of Cancer Treatment MRNA Vaccine
  • Individualized Cancer Treatment MRNA Vaccine
  • Infectious Disease Treatment MRNA Vaccine
  • Infection Prevention MRNA Vaccine
On the basis of the end users/application, this report covers
  • Hospital
  • Clinic
  • Other
If you have any special requirements, please let us know and we will offer you the report as you want.
China mRNA Vaccines & Therapeutics Market Research Report 2018

1 MRNA VACCINES & THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of mRNA Vaccines & Therapeutics
1.2 Classification of mRNA Vaccines & Therapeutics by Product Category
  1.2.1 China mRNA Vaccines & Therapeutics Sales (K Units) Comparison by Type (2013-2025)
  1.2.2 China mRNA Vaccines & Therapeutics Sales (K Units) Market Share by Type in 2017
  1.2.3 Standardization Of Cancer Treatment MRNA Vaccine
  1.2.4 Individualized Cancer Treatment MRNA Vaccine
  1.2.5 Infectious Disease Treatment MRNA Vaccine
  1.2.6 Infection Prevention MRNA Vaccine
1.3 China mRNA Vaccines & Therapeutics Market by Application/End Users
  1.3.1 China mRNA Vaccines & Therapeutics Sales (K Units) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Other
1.4 China mRNA Vaccines & Therapeutics Market by Region
  1.4.1 China mRNA Vaccines & Therapeutics Market Size (Million USD) Comparison by Region (2013-2025)
  1.4.2 South China mRNA Vaccines & Therapeutics Status and Prospect (2013-2025)
  1.4.3 East China mRNA Vaccines & Therapeutics Status and Prospect (2013-2025)
  1.4.4 Southwest China mRNA Vaccines & Therapeutics Status and Prospect (2013-2025)
  1.4.5 Northeast China mRNA Vaccines & Therapeutics Status and Prospect (2013-2025)
  1.4.6 North China mRNA Vaccines & Therapeutics Status and Prospect (2013-2025)
  1.4.7 Central China mRNA Vaccines & Therapeutics Status and Prospect (2013-2025)
1.5 China Market Size (Sales and Revenue) of mRNA Vaccines & Therapeutics (2013-2025)
  1.5.1 China mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%)(2013-2025)
  1.5.2 China mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 CHINA MRNA VACCINES & THERAPEUTICS MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China mRNA Vaccines & Therapeutics Sales and Market Share of Key Players/Manufacturers (2013-2018)
2.2 China mRNA Vaccines & Therapeutics Revenue and Share by Players/Manufacturers (2013-2018)
2.3 China mRNA Vaccines & Therapeutics Average Price (USD/Unit) by Players/Manufacturers (2013-2018)
2.4 China mRNA Vaccines & Therapeutics Market Competitive Situation and Trends
  2.4.1 China mRNA Vaccines & Therapeutics Market Concentration Rate
  2.4.2 China mRNA Vaccines & Therapeutics Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers mRNA Vaccines & Therapeutics Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA MRNA VACCINES & THERAPEUTICS SALES AND REVENUE BY REGION (2013-2018)

3.1 China mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by Region (2013-2018)
3.2 China mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by Region (2013-2018)
3.3 China mRNA Vaccines & Therapeutics Price (USD/Unit) by Regions (2013-2018)

4 CHINA MRNA VACCINES & THERAPEUTICS SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2013-2018)

4.1 China mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by Type/ Product Category (2013-2018)
4.2 China mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by Type (2013-2018)
4.3 China mRNA Vaccines & Therapeutics Price (USD/Unit) by Type (2013-2018)
4.4 China mRNA Vaccines & Therapeutics Sales Growth Rate (%) by Type (2013-2018)

5 CHINA MRNA VACCINES & THERAPEUTICS SALES BY APPLICATION (2013-2018)

5.1 China mRNA Vaccines & Therapeutics Sales (K Units) and Market Share by Application (2013-2018)
5.2 China mRNA Vaccines & Therapeutics Sales Growth Rate (%) by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 CHINA MRNA VACCINES & THERAPEUTICS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Argos Therapeutics
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.1.4 Main Business/Business Overview
6.2 AstraZeneca
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 AstraZeneca mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Bayer
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bayer mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.3.4 Main Business/Business Overview
6.4 BioNTech
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 BioNTech mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Boehringer Ingelheim
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Boehringer Ingelheim mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.5.4 Main Business/Business Overview
6.6 CRISPR Therapeutics
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 CRISPR Therapeutics mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.6.4 Main Business/Business Overview
6.7 CureVac
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 CureVac mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.7.4 Main Business/Business Overview
6.8 eTheRNA immunotherapies
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 eTheRNA immunotherapies mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Ethris
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Ethris mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.9.4 Main Business/Business Overview
6.10 GlaxoSmithKline Vaccines
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.10.4 Main Business/Business Overview
6.11 In-Cell-Art
6.12 Intellia Therapeutics
6.13 Janssen
6.14 Kernal Biologics
6.15 MaxCyte
6.16 Moderna Therapeutics
6.17 Novartis
6.18 PhaseRx
6.19 Precision NanoSystems
6.20 RaNa Therapeutics

7 MRNA VACCINES & THERAPEUTICS MANUFACTURING COST ANALYSIS

7.1 mRNA Vaccines & Therapeutics Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of mRNA Vaccines & Therapeutics

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 mRNA Vaccines & Therapeutics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of mRNA Vaccines & Therapeutics Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA MRNA VACCINES & THERAPEUTICS MARKET SIZE (SALES AND REVENUE) FORECAST (2018-2025)

11.1 China mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD) Forecast (2018-2025)
11.2 China mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Type (2018-2025)
11.3 China mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Application (2018-2025)
11.4 China mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2013-2025)
Table mRNA Vaccines & Therapeutics Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table mRNA Vaccines & Therapeutics Sales (K Units) by Application (2013-2025)
Figure Product Picture of mRNA Vaccines & Therapeutics
Table China mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%) Comparison by Types (Product Category) (2013-2025)
Figure China mRNA Vaccines & Therapeutics Sales Volume Market Share by Types in 2017
Figure Standardization Of Cancer Treatment MRNA Vaccine Product Picture
Figure Individualized Cancer Treatment MRNA Vaccine Product Picture
Figure Infectious Disease Treatment MRNA Vaccine Product Picture
Figure Infection Prevention MRNA Vaccine Product Picture
Figure China mRNA Vaccines & Therapeutics Sales (K Units) Comparison by Application (2013-2025)
Figure China Sales Market Share (%) of mRNA Vaccines & Therapeutics by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Other Examples
Table Key Downstream Customer in Other
Figure South China mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure East China mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest China mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Northeast China mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure North China mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Central China mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure China mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%)(2013-2025)
Figure China mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table China mRNA Vaccines & Therapeutics Sales of Key Players/Manufacturers (2013-2018)
Table China mRNA Vaccines & Therapeutics Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China mRNA Vaccines & Therapeutics Sales Share (%) by Players/Manufacturers
Figure 2017 China mRNA Vaccines & Therapeutics Sales Share (%) by Players/Manufacturers
Table China mRNA Vaccines & Therapeutics Revenue by Players/Manufacturers (2013-2018)
Table China mRNA Vaccines & Therapeutics Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China mRNA Vaccines & Therapeutics Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China mRNA Vaccines & Therapeutics Revenue Market Share (%) by Players/Manufacturers
Table China Market mRNA Vaccines & Therapeutics Average Price of Key Players/Manufacturers (2013-2018)
Figure China Market mRNA Vaccines & Therapeutics Average Price of Key Players/Manufacturers in 2017
Figure China mRNA Vaccines & Therapeutics Market Share of Top 3 Players/Manufacturers
Figure China mRNA Vaccines & Therapeutics Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers mRNA Vaccines & Therapeutics Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers mRNA Vaccines & Therapeutics Product Category
Table China mRNA Vaccines & Therapeutics Sales (K Units) by Regions (2013-2018)
Table China mRNA Vaccines & Therapeutics Sales Share (%) by Regions (2013-2018)
Figure China mRNA Vaccines & Therapeutics Sales Share (%) by Regions (2013-2018)
Figure China mRNA Vaccines & Therapeutics Sales Market Share (%) by Regions in 2017
Table China mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by Regions (2013-2018)
Table China mRNA Vaccines & Therapeutics Revenue Market Share (%) by Regions (2013-2018)
Figure China mRNA Vaccines & Therapeutics Revenue Market Share (%) by Regions (2013-2018)
Figure China mRNA Vaccines & Therapeutics Revenue Market Share (%) by Regions in 2017
Table China mRNA Vaccines & Therapeutics Price (USD/Unit) by Regions (2013-2018)
Table China mRNA Vaccines & Therapeutics Sales (K Units) by Type (2013-2018)
Table China mRNA Vaccines & Therapeutics Sales Share (%) by Type (2013-2018)
Figure China mRNA Vaccines & Therapeutics Sales Share (%) by Type (2013-2018)
Figure China mRNA Vaccines & Therapeutics Sales Market Share (%) by Type in 2017
Table China mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by Type (2013-2018)
Table China mRNA Vaccines & Therapeutics Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of mRNA Vaccines & Therapeutics by Type (2013-2018)
Figure Revenue Market Share of mRNA Vaccines & Therapeutics by Type in 2017
Table China mRNA Vaccines & Therapeutics Price (USD/Unit) by Types (2013-2018)
Figure China mRNA Vaccines & Therapeutics Sales Growth Rate (%) by Type (2013-2018)
Table China mRNA Vaccines & Therapeutics Sales (K Units) by Applications (2013-2018)
Table China mRNA Vaccines & Therapeutics Sales Market Share (%) by Applications (2013-2018)
Figure China mRNA Vaccines & Therapeutics Sales Market Share (%) by Application (2013-2018)
Figure China mRNA Vaccines & Therapeutics Sales Market Share (%) by Application in 2017
Table China mRNA Vaccines & Therapeutics Sales Growth Rate (%) by Application (2013-2018)
Figure China mRNA Vaccines & Therapeutics Sales Growth Rate (%) by Application (2013-2018)
Table Argos Therapeutics mRNA Vaccines & Therapeutics Basic Information List
Table Argos Therapeutics mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Argos Therapeutics mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Argos Therapeutics mRNA Vaccines & Therapeutics Sales Market Share (%) in China (2013-2018)
Figure Argos Therapeutics mRNA Vaccines & Therapeutics Revenue Market Share (%) in China (2013-2018)
Table AstraZeneca mRNA Vaccines & Therapeutics Basic Information List
Table AstraZeneca mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure AstraZeneca mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure AstraZeneca mRNA Vaccines & Therapeutics Sales Market Share (%) in China (2013-2018)
Figure AstraZeneca mRNA Vaccines & Therapeutics Revenue Market Share (%) in China (2013-2018)
Table Bayer mRNA Vaccines & Therapeutics Basic Information List
Table Bayer mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Bayer mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Bayer mRNA Vaccines & Therapeutics Sales Market Share (%) in China (2013-2018)
Figure Bayer mRNA Vaccines & Therapeutics Revenue Market Share (%) in China (2013-2018)
Table BioNTech mRNA Vaccines & Therapeutics Basic Information List
Table BioNTech mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure BioNTech mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure BioNTech mRNA Vaccines & Therapeutics Sales Market Share (%) in China (2013-2018)
Figure BioNTech mRNA Vaccines & Therapeutics Revenue Market Share (%) in China (2013-2018)
Table Boehringer Ingelheim mRNA Vaccines & Therapeutics Basic Information List
Table Boehringer Ingelheim mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Boehringer Ingelheim mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Boehringer Ingelheim mRNA Vaccines & Therapeutics Sales Market Share (%) in China (2013-2018)
Figure Boehringer Ingelheim mRNA Vaccines & Therapeutics Revenue Market Share (%) in China (2013-2018)
Table CRISPR Therapeutics mRNA Vaccines & Therapeutics Basic Information List
Table CRISPR Therapeutics mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure CRISPR Therapeutics mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure CRISPR Therapeutics mRNA Vaccines & Therapeutics Sales Market Share (%) in China (2013-2018)
Figure CRISPR Therapeutics mRNA Vaccines & Therapeutics Revenue Market Share (%) in China (2013-2018)
Table CureVac mRNA Vaccines & Therapeutics Basic Information List
Table CureVac mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure CureVac mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure CureVac mRNA Vaccines & Therapeutics Sales Market Share (%) in China (2013-2018)
Figure CureVac mRNA Vaccines & Therapeutics Revenue Market Share (%) in China (2013-2018)
Table eTheRNA immunotherapies mRNA Vaccines & Therapeutics Basic Information List
Table eTheRNA immunotherapies mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure eTheRNA immunotherapies mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure eTheRNA immunotherapies mRNA Vaccines & Therapeutics Sales Market Share (%) in China (2013-2018)
Figure eTheRNA immunotherapies mRNA Vaccines & Therapeutics Revenue Market Share (%) in China (2013-2018)
Table Ethris mRNA Vaccines & Therapeutics Basic Information List
Table Ethris mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Ethris mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Ethris mRNA Vaccines & Therapeutics Sales Market Share (%) in China (2013-2018)
Figure Ethris mRNA Vaccines & Therapeutics Revenue Market Share (%) in China (2013-2018)
Table GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Basic Information List
Table GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%)(2013-2018)
Figure GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Sales Market Share (%) in China (2013-2018)
Figure GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Revenue Market Share (%) in China (2013-2018)
Table In-Cell-Art mRNA Vaccines & Therapeutics Basic Information List
Table Intellia Therapeutics mRNA Vaccines & Therapeutics Basic Information List
Table Janssen mRNA Vaccines & Therapeutics Basic Information List
Table Kernal Biologics mRNA Vaccines & Therapeutics Basic Information List
Table MaxCyte mRNA Vaccines & Therapeutics Basic Information List
Table Moderna Therapeutics mRNA Vaccines & Therapeutics Basic Information List
Table Novartis mRNA Vaccines & Therapeutics Basic Information List
Table PhaseRx mRNA Vaccines & Therapeutics Basic Information List
Table Precision NanoSystems mRNA Vaccines & Therapeutics Basic Information List
Table RaNa Therapeutics mRNA Vaccines & Therapeutics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of mRNA Vaccines & Therapeutics
Figure Manufacturing Process Analysis of mRNA Vaccines & Therapeutics
Figure mRNA Vaccines & Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of mRNA Vaccines & Therapeutics Major Players/Manufacturers in 2017
Table Major Buyers of mRNA Vaccines & Therapeutics
Table Distributors/Traders List
Figure China mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure China mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China mRNA Vaccines & Therapeutics Price (USD/Unit) Trend Forecast (2018-2025)
Table China mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Type (2018-2025)
Figure China mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Type (2018-2025)
Figure China mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Type in 2025
Table China mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Application (2018-2025)
Figure China mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Application (2018-2025)
Figure China mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Application in 2025
Table China mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Regions (2018-2025)
Table China mRNA Vaccines & Therapeutics Sales Volume Share Forecast by Regions (2018-2025)
Figure China mRNA Vaccines & Therapeutics Sales Volume Share Forecast by Regions (2018-2025)
Figure China mRNA Vaccines & Therapeutics Sales Volume Share Forecast by Regions in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications